Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies.

MLA

Maddaloni, Luca, et al. “Differential Expression of Type I Interferon and Inflammatory Genes in SARS‐CoV‐2‐infected Patients Treated with Monoclonal Antibodies.” Immunity, Inflammation & Disease, vol. 11, no. 10, Oct. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1002/iid3.968.

APA

Maddaloni, L., Santinelli, L., Bugani, G., Cacciola, E. G., Lazzaro, A., Lofaro, C. M., Caiazzo, S., Frasca, F., Fracella, M., Ajassa, C., Leanza, C., Napoli, A., Cinti, L., Gaeta, A., Antonelli, G., Ceccarelli, G., Mastroianni, C. M., Scagnolari, C., & d’Ettorre, G. (2023). Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies. Immunity, Inflammation & Disease, 11(10), 1–11. https://doi.org/10.1002/iid3.968

Chicago

Maddaloni, Luca, Letizia Santinelli, Ginevra Bugani, Elio G. Cacciola, Alessandro Lazzaro, Chiara M. Lofaro, Sara Caiazzo, et al. 2023. “Differential Expression of Type I Interferon and Inflammatory Genes in SARS‐CoV‐2‐infected Patients Treated with Monoclonal Antibodies.” Immunity, Inflammation & Disease 11 (10): 1–11. doi:10.1002/iid3.968.